G Medical Innovations (GMVD) Short Interest Ratio & Short Volume

Short interest is the volume of G Medical Innovations shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 68,800 shares of GMVD short. 4.14% of G Medical Innovations' shares are currently sold short. Learn More on G Medical Innovations' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.14% of G Medical Innovations' floating shares are currently sold short.

G Medical Innovations saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 68,800 shares, an increase of 18.6% from the previous total of 58,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

G Medical Innovations currently has issued a total of 1,964,000 shares. Some of G Medical Innovations' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. G Medical Innovations currently has a public float of 1,660,000 shares.

4.14% of G Medical Innovations' shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to G Medical Innovations: Bluejay Diagnostics, Inc. (6.93%), Sharps Technology, Inc. (22.31%), Boston Scientific Co. (0.99%), Stryker Co. (1.75%), 3M (1.91%), Becton, Dickinson and Company (1.42%), ResMed Inc. (6.25%), DexCom, Inc. (2.72%), Insulet Co. (3.37%), Baxter International Inc. (3.39%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.34 billion), Occidental Petroleum Co. ($2.88 billion), Coinbase Global, Inc. ($2.50 billion), Rivian Automotive, Inc. ($2.47 billion), Palantir Technologies Inc. ($2.37 billion), Royal Caribbean Cruises Ltd. ($2.33 billion), T. Rowe Price Group, Inc. ($2.29 billion), Tractor Supply ($1.59 billion), Upstart Holdings, Inc. ($1.58 billion), and Enphase Energy, Inc. ($1.52 billion). View all of the most shorted stocks.

Short selling GMVD is an investing strategy that aims to generate trading profit from G Medical Innovations as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for G Medical Innovations occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GMVD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GMVD, twice per month. The most recent reporting period available is July, 31 2023.